Detalhe da pesquisa
1.
Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell function.
Int J Cancer
; 154(3): 425-433, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728485
2.
Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.
J Oral Pathol Med
; 51(2): 126-133, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878693
3.
LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway.
Biochem Biophys Res Commun
; 537: 93-99, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388415
4.
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours.
Br J Cancer
; 122(5): 658-667, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857719
5.
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer.
Br J Cancer
; 122(9): 1333-1341, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152502
6.
Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.
Int J Cancer
; 142(5): 1056-1066, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29055044
7.
Leucine rich α-2 glycoprotein is a potential urinary biomarker for renal tubular injury.
Biochem Biophys Res Commun
; 498(4): 1045-1051, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550485
8.
SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling.
Gastric Cancer
; 21(6): 968-976, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29623544
9.
Leucine-rich α2-glycoprotein as a useful biomarker for evaluating disease activity in rheumatoid arthritis.
Mod Rheumatol
; 2023 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141246
10.
Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
Int J Cancer
; 140(11): 2608-2621, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28233302
11.
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.
Br J Cancer
; 115(1): 66-75, 2016 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27310703
12.
Salt-inducible kinase 3 deficiency exacerbates lipopolysaccharide-induced endotoxin shock accompanied by increased levels of pro-inflammatory molecules in mice.
Immunology
; 145(2): 268-78, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25619259
13.
Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.
Exp Dermatol
; 24(11): 864-71, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26173926
14.
The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells.
J Immunol
; 186(1): 32-40, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21106853
15.
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer.
Neoplasia
; 35: 100853, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413881
16.
Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody.
Anticancer Res
; 43(6): 2425-2432, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247902
17.
SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study.
Anticancer Res
; 42(7): 3361-3372, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790291
18.
Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expression.
Int Immunol
; 22(5): 359-66, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20190037
19.
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.
Proc Natl Acad Sci U S A
; 105(26): 9041-6, 2008 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18577591
20.
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.
Oncotarget
; 12(21): 2232-2233, 2021 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676057